de Paus RA - Search Results

1

Proteosomal degradation of BCR/ABL protein can generate an HLA-A*0301-restricted peptide, but high-avidity T cells recognizing this leukemia-specific antigen were not demonstrated.

Posthuma EF, van Bergen CA, Kester MG, de Paus RA, van Veelen PA, de Ru AH, Drijfhout JW, Lurvink EG, Willemze R, Falkenburg JH. Posthuma EF, et al. Among authors: de ru ah, de paus ra. Haematologica. 2004 Sep;89(9):1062-71. Haematologica. 2004. PMID: 15377467

2

Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region.

Heemskerk MH, Hoogeboom M, de Paus RA, Kester MG, van der Hoorn MA, Goulmy E, Willemze R, Falkenburg JH. Heemskerk MH, et al. Among authors: de paus ra. Blood. 2003 Nov 15;102(10):3530-40. doi: 10.1182/blood-2003-05-1524. Epub 2003 Jul 17. Blood. 2003. PMID: 12869497 Free article.

3

Antisense-mediated exon skipping to correct IL-12Rbeta1 deficiency in T cells.

van de Vosse E, Verhard EM, de Paus RA, Platenburg GJ, van Deutekom JC, Aartsma-Rus A, van Dissel JT. van de Vosse E, et al. Among authors: de paus ra. Blood. 2009 May 7;113(19):4548-55. doi: 10.1182/blood-2008-12-196220. Epub 2009 Mar 3. Blood. 2009. PMID: 19258592 Free article.

4

Functional analysis of naturally occurring amino acid substitutions in human IFN-gammaR1.

van de Wetering D, de Paus RA, van Dissel JT, van de Vosse E. van de Wetering D, et al. Among authors: de paus ra. Mol Immunol. 2010 Feb;47(5):1023-30. doi: 10.1016/j.molimm.2009.11.016. Epub 2009 Dec 16. Mol Immunol. 2010. PMID: 20015550

5

Effect of amino acid substitutions in the human IFN-γR2 on IFN-γ responsiveness.

de Paus RA, Kilic SS, van Dissel JT, van de Vosse E. de Paus RA, et al. Genes Immun. 2011 Mar;12(2):136-44. doi: 10.1038/gene.2010.74. Epub 2011 Jan 20. Genes Immun. 2011. PMID: 21248774

6

Molecular complementation of IL-12Rbeta1 deficiency reveals functional differences between IL-12Rbeta1 alleles including partial IL-12Rbeta1 deficiency.

van de Vosse E, de Paus RA, van Dissel JT, Ottenhoff TH. van de Vosse E, et al. Among authors: de paus ra. Hum Mol Genet. 2005 Dec 15;14(24):3847-55. doi: 10.1093/hmg/ddi409. Epub 2005 Nov 17. Hum Mol Genet. 2005. PMID: 16293671

7

IL-23 and IL-12 responses in activated human T cells retrovirally transduced with IL-23 receptor variants.

de Paus RA, van de Wetering D, van Dissel JT, van de Vosse E. de Paus RA, et al. Mol Immunol. 2008 Sep;45(15):3889-95. doi: 10.1016/j.molimm.2008.06.029. Mol Immunol. 2008. PMID: 18675459

8

A mosaic de novo duplication of 17q21-25 is associated with GH insensitivity, disturbed in vitro CD28-mediated signaling, and decreased STAT5B, PI3K, and NF-κB activation.

Mul D, Wu S, de Paus RA, Oostdijk W, Lankester AC, Duyvenvoorde HA, Ruivenkamp CA, Losekoot M, Tol MJ, De Luca F, van de Vosse E, Wit JM. Mul D, et al. Among authors: de luca f, de paus ra. Eur J Endocrinol. 2012 Apr;166(4):743-52. doi: 10.1530/EJE-11-0774. Epub 2012 Jan 3. Eur J Endocrinol. 2012. PMID: 22214923

9

IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12.

van de Wetering D, de Paus RA, van Dissel JT, van de Vosse E. van de Wetering D, et al. Among authors: de paus ra. Int Immunol. 2009 Feb;21(2):145-53. doi: 10.1093/intimm/dxn132. Epub 2008 Dec 15. Int Immunol. 2009. PMID: 19088061

10

Inhibition of the type I immune responses of human monocytes by IFN-α and IFN-β.

de Paus RA, van Wengen A, Schmidt I, Visser M, Verdegaal EM, van Dissel JT, van de Vosse E. de Paus RA, et al. Cytokine. 2013 Feb;61(2):645-55. doi: 10.1016/j.cyto.2012.12.005. Epub 2013 Jan 5. Cytokine. 2013. PMID: 23299081

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page